Bluejay Diagnostics, Inc. 8-K

What Happened

• Bluejay Diagnostics, Inc. announced on May 7, 2026 (via a Form 8-K, Item 2.02) that it issued a press release providing a corporate update and certain financial results for the fiscal quarter ended March 31, 2026.
• The press release is furnished with the 8-K as Exhibit 99.1.

Key Details

• Filing date: May 7, 2026 (Form 8-K, Item 2.02 – Results of Operations and Financial Condition).
• Reporting period: fiscal quarter ended March 31, 2026.
• Disclosure delivered via press release attached as Exhibit 99.1 to the 8-K.
• The filing also includes the standard Inline XBRL cover page filing (Item 9.01 exhibits).

Why It Matters

• Quarterly results and corporate updates provide the latest data on Bluejay’s operating performance and financial position; these can affect investor decisions and share price once the market digests the figures.
• Retail investors should read the press release (Exhibit 99.1) for the specific revenue, expense, cash or operational details disclosed, and consult the company’s subsequent periodic filings (e.g., Form 10-Q) for full financial statements and management discussion.